1. Home
  2. BCPC vs LEGN Comparison

BCPC vs LEGN Comparison

Compare BCPC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCPC
  • LEGN
  • Stock Information
  • Founded
  • BCPC 1967
  • LEGN 2014
  • Country
  • BCPC United States
  • LEGN United States
  • Employees
  • BCPC N/A
  • LEGN N/A
  • Industry
  • BCPC Major Chemicals
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCPC Industrials
  • LEGN Health Care
  • Exchange
  • BCPC Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • BCPC 5.2B
  • LEGN 5.4B
  • IPO Year
  • BCPC N/A
  • LEGN 2020
  • Fundamental
  • Price
  • BCPC $157.82
  • LEGN $37.66
  • Analyst Decision
  • BCPC Strong Buy
  • LEGN Strong Buy
  • Analyst Count
  • BCPC 1
  • LEGN 11
  • Target Price
  • BCPC $189.00
  • LEGN $74.60
  • AVG Volume (30 Days)
  • BCPC 186.9K
  • LEGN 1.3M
  • Earning Date
  • BCPC 07-31-2025
  • LEGN 08-11-2025
  • Dividend Yield
  • BCPC 0.55%
  • LEGN N/A
  • EPS Growth
  • BCPC 21.42
  • LEGN N/A
  • EPS
  • BCPC 4.36
  • LEGN N/A
  • Revenue
  • BCPC $985,930,000.00
  • LEGN $728,303,000.00
  • Revenue This Year
  • BCPC $8.74
  • LEGN $66.76
  • Revenue Next Year
  • BCPC $6.85
  • LEGN $52.58
  • P/E Ratio
  • BCPC $36.14
  • LEGN N/A
  • Revenue Growth
  • BCPC 5.74
  • LEGN 112.46
  • 52 Week Low
  • BCPC $145.70
  • LEGN $27.34
  • 52 Week High
  • BCPC $185.96
  • LEGN $59.62
  • Technical
  • Relative Strength Index (RSI)
  • BCPC 51.68
  • LEGN 42.35
  • Support Level
  • BCPC $147.74
  • LEGN $38.10
  • Resistance Level
  • BCPC $157.00
  • LEGN $39.16
  • Average True Range (ATR)
  • BCPC 3.72
  • LEGN 1.50
  • MACD
  • BCPC 0.73
  • LEGN -0.79
  • Stochastic Oscillator
  • BCPC 72.49
  • LEGN 9.59

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: